查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
基因分型市場規模和預測、全球和區域佔有率、趨勢和成長機會分析報告範圍：按產品類型、技術、應用、最終用戶和地理位置
市場調查報告書
商品編碼
1558399

基因分型市場規模和預測、全球和區域佔有率、趨勢和成長機會分析報告範圍：按產品類型、技術、應用、最終用戶和地理位置

Genotyping Market Size and Forecast, Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product Type, Technology, Application, End User, and Geography
出版日期: | 出版商: The Insight Partners | 英文 250 Pages | 訂單完成後即時交付

價格

依據「到 2031 年基因分型市場預測 - 全球分析 - 按產品類型、技術、應用、最終用戶和地理位置」的新研究，該市場預計將從 2023 年的 304.4 億美元成長到2031年達到1543.5億美元；預計 2023-2031 年複合年成長率為 22.5%。用於診斷遺傳和罕見疾病、生物技術和製藥行業的技術進步和研發投資的增加是促進基因分型市場成長的因素。然而，設備成本高昂和熟練專業人員的短缺阻礙了市場的成長。此外，個人化醫療的日益普及預計將在未來幾年帶來新的基因分型市場趨勢。

基因分型是製藥業最有前景的途徑之一，為治療各種疾病和醫療狀況提供了獨特的方法。由於製藥和生技公司投入大量資金改善其生產設施，基因分型市場不斷成長。慢性病病例和診斷數量的增加需要複雜的診斷和治療藥物的可用性，這推動了全球基因分型市場的發展。此外，不斷成長的需求、對創新療法的更高接受度以及不斷增加的臨床試驗預計將推動市場成長。然而，生物相似藥的批准是限制基因分型市場擴張的主要方面之一。

2023年，北美佔據全球基因分型市場的主要佔有率。擴大採用技術先進的產品和解決方案，以及激增的研發活動是有利於該地區基因分型市場的因素。此外，政府主導的計畫（例如「我們所有人研究計畫」）、各個基因組社區的計劃以及對基因分型服務的認知不斷提高是整個北美市場擴張的關鍵驅動力。

由美國國立衛生研究院 (NIH) 領導的正在進行的「我們所有人研究計劃」提供了 2860 萬美元的資金，用於在美國建立三個基因組中心。該研究計畫旨在透過美國不同機構的基因分型服務加速精準醫學的發現。同樣，啟動了「我的生活，我們的未來」項目，對血友病患者進行基因分型，並建立一個生物樣本庫作為未來的研究資源。此外，醫療保健支出的快速成長反映出遺傳疾病和癌症的新診斷工具的可用性不斷增加。蓬勃發展的製藥和生物製藥產業為美國基因分型市場創造了有利的環境。該國的市場參與者已為其創新註冊了各種專利。

各國政府和私營農業協會高度關注作物基因組學的進步，以改善作物的特性。國家糧食和農業研究所的農業基因組到表現型組計劃（AG2PI）側重於合作，發展研究作物和動物遺傳學的研究人員社區，這將為擴展關於基因組和表現型組的知識奠定基礎，這對於農業和農業至關重要。該計劃可能會導致開發出一些方法來了解多變的天氣、環境和生產系統如何影響農作物和動物的遺傳多樣性。因此，越來越多的措施促進與農作物基因組成相關的研究，以提高產量和質量，未來可能有利於美國的基因分型市場。

擴大應用範圍，為未來提供市場機會

基因分型在診斷研究、藥物基因體學和農業生物技術中具有潛在的應用。此外，該技術適用於各種植物育種、法醫和環境測試程序。製藥公司受益於多基因風險評分、與患者健康資訊相關的大量基因資料庫以及臨床試驗參與者的定序資料等進步。產業藥物基因組學工作小組 (I-PWG) 是一個製藥公司協會，積極參與藥物基因組學研究。 I-PWG 由 26 家成員公司組成，每年進行大量臨床試驗，收集研究對象的 DNA 樣本作為協議的一部分。 I-PWG 專注於臨床藥物基因組學，旨在在未來幾年為製藥公司創造機會。除了最常用於腫瘤學研究之外，它還用於非腫瘤治療領域（例如罕見疾病、免疫學和心臟病學）進行的 PGx 研究。一項更全面的研究，涉及臨床試驗樣本的 NGS，可以對試驗參與者進行詳細的基因組評估，揭示常見和罕見的遺傳變異。 PGx 包括在確定基因組層級藥物/異生素效應、藥物反應和疾病易感性以及基因型/表現型關係方面的多態性差異研究。

定序基因分型（GBS）是一種利用NGS方法對作物基因組和人類基因組中的SNP進行定位和基因分型的新方法。 GBS 被開發並部署在多個樣本的定序中，透過在此過程中加入分子標記，進一步增強 NGS 在玉米和小麥等巨型作物基因組定序中的應用。 GBS檢測的高通量SNP廣泛應用於許多植物物種的遺傳多樣性分析、全基因組關聯研究(GWAS)、QTL定位和基因組預測(GP)。 NGS技術以高通量和低成本改變了現代生物學。隨著 NGS 技術的顯著進步，全基因組定序提供了超高通量序列，徹底改變了植物性因分型和育種。邊合成邊定序（SBS）和多重定序大大提高了定序效率。

因此，在各個研究領域中更多地採用基因分型最終將導致對這些技術的需求增加，從而在市場上創造重大機會。

基因分型市場：競爭格局與主要發展

F. Hoffmann-La Roche Ltd.、Integrated DNA Technologies, Inc. (Danaher)、Qiagen、Merck KGaA、Eurofins Genomics、Thermo Fisher Scientific Inc.、BioTek Instruments, Inc.、Xcelris Genomics、Trimgen Corporation 和 Illumina, Inc.基因分型市場上的主要公司之一。

美國食品藥物管理局、疾病管制與預防中心 (CDC) 以及經濟合作暨發展組織是準備基因分型市場報告時參考的主要和次要來源。

目錄

第 1 章：簡介

第 2 章：執行摘要

  • 主要見解

第 3 章：研究方法

  • 二次研究
  • 初步研究
    • 假設表述：
    • 宏觀經濟因素分析：
    • 顯影基數：
    • 數據三角測量：
    • 國家級資料：

第 4 章：基因分型市場格局

  • 概述
  • PEST分析
  • 全球市佔率分析
    • NGS 文庫製備領先廠商的全球市佔率 (%)
    • 基因分型領先廠商的全球市佔率 (%)
    • 基因表現領域領導企業的全球市場佔有率 (%)

第 5 章：基因分型市場 - 主要市場動態

  • 基因分型市場 - 主要市場動態
  • 市場促進因素：
    • 用於診斷遺傳疾病和罕見疾病
    • 生物技術和製藥行業的技術進步和研發投資的增加
  • 市場限制
    • 設備成本高，技術人員短缺
  • 市場機會
    • 擴大應用範圍
  • 未來趨勢
    • 個人化醫療越來越受歡迎
  • 促進因素和限制的影響：

第 6 章：基因分型市場 - 全球市場分析

  • 基因分型市場收入，2021-2031

第 7 章：基因分型市場分析 - 依產品類型

  • 儀器儀表
  • 試劑和試劑盒
  • 生物資訊學
  • 基因分型服務

第 8 章：基因分型市場分析 - 依技術

  • 微陣列
  • 毛細管電泳
  • 定序
  • 聚合酶鍊式反應 (PCR)
  • 基質輔助雷射解吸/MALDI-TOF
  • 其他技術

第 9 章：基因分型市場分析 - 按應用

  • 藥物基因組學
  • 診斷及個人化醫療
  • 動物遺傳學
  • 農業生物技術
  • 其他應用

第 10 章：基因分型市場分析 - 依最終用戶

  • 製藥和生物製藥公司
  • 診斷與研究實驗室
  • 學術機構
  • 其他最終用戶

第 11 章：基因分型市場 - 地理分析

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 西班牙
    • 義大利
    • 歐洲其他地區
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 澳洲
    • 韓國
    • 亞太地區其他地區
  • 中東和非洲
    • 沙烏地阿拉伯
    • 南非
    • 阿拉伯聯合大公國
    • 中東和非洲其他地區

第 12 章：產業格局

  • 概述
  • 基因分型市場的成長策略
  • 有機成長策略
    • 概述
  • 無機成長策略
    • 概述

第 13 章：公司簡介

  • Hoffmann-La Roche Ltd
  • QIAGEN NV
  • Merck KGaA
  • EUROFINS GENOMICS
  • Thermo Fisher Scientific Inc
  • BioTek Instruments, Inc.
  • XCELRIS GENOMICS
  • TRIMGEN CORPORATION
  • Illumina Inc
  • Danaher Corp
  • Bio-Rad Laboratories Inc
  • GE HealthCare Technologies Inc
  • Standard BioTools Inc
  • Laboratory Corp of America Holdings
  • Beckman Coulter Inc
  • BGI
  • Takara Bio Inc
  • DiaSorin SpA

第 14 章：附錄

Product Code: TIPHE100001166

According to our new research study on "Genotyping Market Forecast to 2031 - Global Analysis - by Product Type, Technology, Application, End User, and Geography," the market is anticipated to grow from US$ 30.44 billion in 2023 and is projected to reach US$ 154.35 billion by 2031; it is expected to register a CAGR of 22.5% during 2023-2031. Use in the diagnosis of genetic and rare diseases, and technological advancements and rising R&D investments in the biotechnology and pharmaceutical industries are among the factors contributing to genotyping market growth. However, the high cost of equipment and shortage of skilled professionals hamper the market growth. Further, the increasing popularity of personalized medicine is expected to bring new genotyping market trends in the coming years.

Genotyping are among the most promising avenues in the pharmaceutical industry, offering a unique approach to treating various diseases and medical conditions. The genotyping market is constantly growing because pharma and biotechnology companies enormously invest in improving their production facilities. The increasing number of cases and diagnoses of chronic diseases requires the availability of sophisticated diagnostic and treatment drugs, which has boosted the global genotyping market. Furthermore, rising demand, higher acceptance of innovative therapies, and increasing clinical trials are expected to drive market growth. However, approving biosimilars is one of the main aspects limiting the genotyping market expansion.

North America accounted for a major share of the global genotyping market in 2023. The North America genotyping market is segmented into the US, Canada, and Mexico. Increasing adoption of technologically advanced products and solutions, and surging research and development activities are the factors benefiting the genotyping market in this region. Moreover, government-led programs such as the "All of Us Research Program," initiatives by various genomic communities, and the increasing awareness of genotyping services are the key drivers of the market expansion across North America.

The ongoing "All of Us Research Program" led by the National Institutes of Health (NIH) provided US$ 28.6 million in funding to develop three genome centers across the US. This research program aims to accelerate precision medicine discoveries through genotyping services in different institutions in the US. Similarly, the "My Life, Our Future" project was initiated to carry out genotyping of hemophilia patients and to build a biorepository as a research resource for the future. Further, a rapid surge in healthcare expenditure reflects the increasing availability of new diagnostic tools for genetic diseases and cancer. The flourishing pharmaceutical and biopharmaceutical industry creates a conducive environment for the genotyping market in the US. Market players in this country have registered various patents for their innovations.

Governments and private agricultural associations are highly focused on advancements in crop genomics to improve the characteristics of crops. The Agricultural Genome to Phenome Initiative (AG2PI) of the National Institute of Food and Agriculture focuses on collaborative engagements to develop a community of researchers studying both crop and animal genetics, which would lay the foundation for expanding knowledge about genomes and phenomes that are important to the agriculture sector in the US. The initiative is likely to result in the development of approaches to understanding how variable weather, environments, and production systems impact genetic diversity in crops and animals. Thus, the rising number of initiatives taken to foster studies related to the genetic makeup of crops for yield and quality improvement are likely to favor the genotyping market in the US in the future.

Expanding Range of Applications to Provide Market Opportunities in Future

Genotyping holds potential applications in diagnostic research, pharmacogenomics, and agricultural biotechnology. Moreover, this technique is suitable for a variety of plant breeding, forensic, and environmental testing procedures. Pharmaceutical companies are profiting from the availability of polygenic risk scores, substantial genetic databases linked to patient health information, and the sequencing data of clinical trial participants, among other advancements. The Industry Pharmacogenomics Working Group (I-PWG), an association of pharmaceutical companies, is actively involved in pharmacogenomic research. The I-PWG comprises 26 member companies that undertake numerous clinical trials annually, collecting DNA samples of study subjects as part of the protocol. With its focus on clinical pharmacogenomics, the I-PWG aims to generate opportunities for pharmaceutical companies in the coming years. In addition to its most frequent use in oncology research, it is also used for PGx studies conducted in non-oncology therapeutic areas such as rare diseases, immunology, and cardiology. A more comprehensive study, involving the NGS of clinical trial samples, allows for an elaborate genomic evaluation of trial participants, revealing both common and rare genetic variations. PGx includes the study of polymorphic differences in the determination of genomic-level drug/xenobiotic effects, drug response and disease susceptibility, and genotype/phenotype relationships.

Genotyping-by-sequencing (GBS) is a new method to locate and genotype SNPs in crop genomes and human genome by using NGS methods. GBS is developed and deployed in sequencing multiple samples by incorporating molecular markers in the process to further enhance NGS applications in giant crop genome sequencing, such as maize and wheat. High-throughput SNPs detected by GBS are widely used in genetic diversity analysis, genome-wide association studies (GWAS), QTL mapping, and genome prediction (GP) in many plant species. NGS technology has transformed modern biology with high throughput and low cost. With remarkable advancements unlocked by NGS technologies, whole-genome sequencing provides ultra-throughput sequences that revolutionize plant genotyping and breeding. Sequencing by synthesis (SBS) and multiplexing greatly enhance the efficiency of the sequence.

Therefore, greater adoption of genotyping in various research areas would eventually lead to a rise in the demand for these techniques, creating significant opportunities in the market.

Genotyping Market: Competitive Landscape and Key Developments

F. Hoffmann-La Roche Ltd., Integrated DNA Technologies, Inc. (Danaher), Qiagen, Merck KGaA, Eurofins Genomics, Thermo Fisher Scientific Inc., BioTek Instruments, Inc., Xcelris Genomics, Trimgen Corporation, and Illumina, Inc. are among the key companies operating in the genotyping market.

The US Food and Drug Administration, Centers for Disease Control and Prevention (CDC), and Organisation for Economic Co-operation and Development are among the primary and secondary sources referred to while preparing the genotyping market report.

Table Of Contents

1. Introduction

  • 1.1 The Insight Partners Research Report Guidance
  • 1.2 Market Segmentation

2. Executive Summary

  • 2.1 Key Insights

3. Research Methodology

  • 3.1 Secondary Research
  • 3.2 Primary Research
    • 3.2.1 Hypothesis formulation:
    • 3.2.2 Macro-economic factor analysis:
    • 3.2.3 Developing base number:
    • 3.2.4 Data Triangulation:
    • 3.2.5 Country level data:

4. Genotyping Market Landscape

  • 4.1 Overview
  • 4.2 PEST Analysis
  • 4.3 Global Market Share Analysis
    • 4.3.1 Global Market Share (%) of Leading Players for NGS Library Preparation
    • 4.3.2 Global Market Share (%) of Leading Player for Genotyping
    • 4.3.3 Global Market Share (%) of Leading Player for Gene Expression

5. Genotyping Market - Key Market Dynamics

  • 5.1 Genotyping Market - Key Market Dynamics
  • 5.2 Market Drivers:
    • 5.2.1 Use in Diagnosis of Genetic and Rare Diseases
    • 5.2.2 Technological Advancements and Rising R&D Investments in Biotechnology and Pharmaceutical Industry
  • 5.3 Market Restraints
    • 5.3.1 High Cost of Equipment and Shortage of Skilled Professionals
  • 5.4 Market Opportunities
    • 5.4.1 Expanding Range of Applications
  • 5.5 Future Trends
    • 5.5.1 Increasing Popularity of Personalized Medicine
  • 5.6 Impact of Drivers and Restraints:

6. Genotyping Market - Global Market Analysis

  • 6.1 Genotyping Market Revenue (US$ Million), 2021-2031

7. Genotyping Market Analysis - by Product Type

  • 7.1 Instruments
    • 7.1.1 Overview
    • 7.1.2 Instruments: Genotyping Market - Revenue and Forecast to 2031 (US$ Million)
  • 7.2 Reagents and Kits
    • 7.2.1 Overview
    • 7.2.2 Reagents and Kits: Genotyping Market - Revenue and Forecast to 2031 (US$ Million)
  • 7.3 Bioinformatics
    • 7.3.1 Overview
    • 7.3.2 Bioinformatics: Genotyping Market - Revenue and Forecast to 2031 (US$ Million)
  • 7.4 Genotyping Services
    • 7.4.1 Overview
    • 7.4.2 Genotyping Services: Genotyping Market - Revenue and Forecast to 2031 (US$ Million)

8. Genotyping Market Analysis - by Technology

  • 8.1 Microarray
    • 8.1.1 Overview
    • 8.1.2 Microarray: Genotyping Market - Revenue and Forecast to 2031 (US$ Million)
  • 8.2 Capillary Electrophoresis
    • 8.2.1 Overview
    • 8.2.2 Capillary Electrophoresis: Genotyping Market - Revenue and Forecast to 2031 (US$ Million)
  • 8.3 Sequencing
    • 8.3.1 Overview
    • 8.3.2 Sequencing: Genotyping Market - Revenue and Forecast to 2031 (US$ Million)
  • 8.4 Polymerase Chain Reaction (PCR)
    • 8.4.1 Overview
    • 8.4.2 Polymerase Chain Reaction (PCR): Genotyping Market - Revenue and Forecast to 2031 (US$ Million)
  • 8.5 Matrix-Assisted Laser Desorption / MALDI-TOF
    • 8.5.1 Overview
    • 8.5.2 Matrix-Assisted Laser Desorption / MALDI-TOF: Genotyping Market - Revenue and Forecast to 2031 (US$ Million)
  • 8.6 Other Technologies
    • 8.6.1 Overview
    • 8.6.2 Other Technologies: Genotyping Market - Revenue and Forecast to 2031 (US$ Million)

9. Genotyping Market Analysis - by Application

  • 9.1 Pharmacogenomics
    • 9.1.1 Overview
    • 9.1.2 Pharmacogenomics: Genotyping Market - Revenue and Forecast to 2031 (US$ Million)
  • 9.2 Diagnostics and Personalized Medicine
    • 9.2.1 Overview
    • 9.2.2 Diagnostics and Personalized Medicine: Genotyping Market - Revenue and Forecast to 2031 (US$ Million)
  • 9.3 Animal Genetics
    • 9.3.1 Overview
    • 9.3.2 Animal Genetics: Genotyping Market - Revenue and Forecast to 2031 (US$ Million)
  • 9.4 Agricultural Biotechnology
    • 9.4.1 Overview
    • 9.4.2 Agricultural Biotechnology: Genotyping Market - Revenue and Forecast to 2031 (US$ Million)
  • 9.5 Other Applications
    • 9.5.1 Overview
    • 9.5.2 Other Applications: Genotyping Market - Revenue and Forecast to 2031 (US$ Million)

10. Genotyping Market Analysis - by End-user

  • 10.1 Pharmaceutical and Biopharmaceutical Companies
    • 10.1.1 Overview
    • 10.1.2 Pharmaceutical and Biopharmaceutical Companies: Genotyping Market - Revenue and Forecast to 2031 (US$ Million)
  • 10.2 Diagnostic and Research Laboratories
    • 10.2.1 Overview
    • 10.2.2 Diagnostic and Research Laboratories: Genotyping Market - Revenue and Forecast to 2031 (US$ Million)
  • 10.3 Academic Institutes
    • 10.3.1 Overview
    • 10.3.2 Academic Institutes: Genotyping Market - Revenue and Forecast to 2031 (US$ Million)
  • 10.4 Other End Users
    • 10.4.1 Overview
    • 10.4.2 Other End Users: Genotyping Market - Revenue and Forecast to 2031 (US$ Million)

11. Genotyping Market - Geographical Analysis

  • 11.1 Overview
  • 11.2 North America
    • 11.2.1 North America Genotyping Market Overview
    • 11.2.2 North America: Genotyping Market - Revenue and Forecast to 2031 (US$ Million)
      • 11.2.2.1 North America: Genotyping Market - Revenue and Forecast Analysis - by Product Type
      • 11.2.2.2 North America: Genotyping Market - Revenue and Forecast Analysis - by Technology
      • 11.2.2.3 North America: Genotyping Market - Revenue and Forecast Analysis - by Application
      • 11.2.2.4 North America: Genotyping Market - Revenue and Forecast Analysis - by End-user
    • 11.2.3 North America: Genotyping Market - Revenue and Forecast Analysis - by Country
      • 11.2.3.1 United States: Genotyping Market - Revenue and Forecast to 2031 (US$ Million)
        • 11.2.3.1.1 United States: Genotyping Market Breakdown, by Product Type
        • 11.2.3.1.2 United States: Genotyping Market Breakdown, by Technology
        • 11.2.3.1.3 United States: Genotyping Market Breakdown, by Application
        • 11.2.3.1.4 United States: Genotyping Market Breakdown, by End-user
      • 11.2.3.2 Canada: Genotyping Market - Revenue and Forecast to 2031 (US$ Million)
        • 11.2.3.2.1 Canada: Genotyping Market Breakdown, by Product Type
        • 11.2.3.2.2 Canada: Genotyping Market Breakdown, by Technology
        • 11.2.3.2.3 Canada: Genotyping Market Breakdown, by Application
        • 11.2.3.2.4 Canada: Genotyping Market Breakdown, by End-user
      • 11.2.3.3 Mexico: Genotyping Market - Revenue and Forecast to 2031 (US$ Million)
        • 11.2.3.3.1 Mexico: Genotyping Market Breakdown, by Product Type
        • 11.2.3.3.2 Mexico: Genotyping Market Breakdown, by Technology
        • 11.2.3.3.3 Mexico: Genotyping Market Breakdown, by Application
        • 11.2.3.3.4 Mexico: Genotyping Market Breakdown, by End-user
  • 11.3 Europe
    • 11.3.1 Europe Genotyping Market Overview
    • 11.3.2 Europe: Genotyping Market - Revenue and Forecast to 2031 (US$ Million)
      • 11.3.2.1 Europe: Genotyping Market - Revenue and Forecast Analysis - by Product Type
      • 11.3.2.2 Europe: Genotyping Market - Revenue and Forecast Analysis - by Technology
      • 11.3.2.3 Europe: Genotyping Market - Revenue and Forecast Analysis - by Application
      • 11.3.2.4 Europe: Genotyping Market - Revenue and Forecast Analysis - by End-user
    • 11.3.3 Europe: Genotyping Market - Revenue and Forecast Analysis - by Country
      • 11.3.3.1 United Kingdom: Genotyping Market - Revenue and Forecast to 2031 (US$ Million)
        • 11.3.3.1.1 United Kingdom: Genotyping Market Breakdown, by Product Type
        • 11.3.3.1.2 United Kingdom: Genotyping Market Breakdown, by Technology
        • 11.3.3.1.3 United Kingdom: Genotyping Market Breakdown, by Application
        • 11.3.3.1.4 United Kingdom: Genotyping Market Breakdown, by End-user
      • 11.3.3.2 Germany: Genotyping Market - Revenue and Forecast to 2031 (US$ Million)
        • 11.3.3.2.1 Germany: Genotyping Market Breakdown, by Product Type
        • 11.3.3.2.2 Germany: Genotyping Market Breakdown, by Technology
        • 11.3.3.2.3 Germany: Genotyping Market Breakdown, by Application
        • 11.3.3.2.4 Germany: Genotyping Market Breakdown, by End-user
      • 11.3.3.3 France: Genotyping Market - Revenue and Forecast to 2031 (US$ Million)
        • 11.3.3.3.1 France: Genotyping Market Breakdown, by Product Type
        • 11.3.3.3.2 France: Genotyping Market Breakdown, by Technology
        • 11.3.3.3.3 France: Genotyping Market Breakdown, by Application
        • 11.3.3.3.4 France: Genotyping Market Breakdown, by End-user
      • 11.3.3.4 Spain: Genotyping Market - Revenue and Forecast to 2031 (US$ Million)
        • 11.3.3.4.1 Spain: Genotyping Market Breakdown, by Product Type
        • 11.3.3.4.2 Spain: Genotyping Market Breakdown, by Technology
        • 11.3.3.4.3 Spain: Genotyping Market Breakdown, by Application
        • 11.3.3.4.4 Spain: Genotyping Market Breakdown, by End-user
      • 11.3.3.5 Italy: Genotyping Market - Revenue and Forecast to 2031 (US$ Million)
        • 11.3.3.5.1 Italy: Genotyping Market Breakdown, by Product Type
        • 11.3.3.5.2 Italy: Genotyping Market Breakdown, by Technology
        • 11.3.3.5.3 Italy: Genotyping Market Breakdown, by Application
        • 11.3.3.5.4 Italy: Genotyping Market Breakdown, by End-user
      • 11.3.3.6 Rest of Europe: Genotyping Market - Revenue and Forecast to 2031 (US$ Million)
        • 11.3.3.6.1 Rest of Europe: Genotyping Market Breakdown, by Product Type
        • 11.3.3.6.2 Rest of Europe: Genotyping Market Breakdown, by Technology
        • 11.3.3.6.3 Rest of Europe: Genotyping Market Breakdown, by Application
        • 11.3.3.6.4 Rest of Europe: Genotyping Market Breakdown, by End-user
  • 11.4 Asia Pacific
    • 11.4.1 Asia Pacific Genotyping Market Overview
    • 11.4.2 Asia Pacific: Genotyping Market - Revenue and Forecast to 2031 (US$ Million)
      • 11.4.2.1 Asia Pacific: Genotyping Market - Revenue and Forecast Analysis - by Product Type
      • 11.4.2.2 Asia Pacific: Genotyping Market - Revenue and Forecast Analysis - by Technology
      • 11.4.2.3 Asia Pacific: Genotyping Market - Revenue and Forecast Analysis - by Application
      • 11.4.2.4 Asia Pacific: Genotyping Market - Revenue and Forecast Analysis - by End-user
    • 11.4.3 Asia Pacific: Genotyping Market - Revenue and Forecast Analysis - by Country
      • 11.4.3.1 China: Genotyping Market - Revenue and Forecast to 2031 (US$ Million)
        • 11.4.3.1.1 China: Genotyping Market Breakdown, by Product Type
        • 11.4.3.1.2 China: Genotyping Market Breakdown, by Technology
        • 11.4.3.1.3 China: Genotyping Market Breakdown, by Application
        • 11.4.3.1.4 China: Genotyping Market Breakdown, by End-user
      • 11.4.3.2 Japan: Genotyping Market - Revenue and Forecast to 2031 (US$ Million)
        • 11.4.3.2.1 Japan: Genotyping Market Breakdown, by Product Type
        • 11.4.3.2.2 Japan: Genotyping Market Breakdown, by Technology
        • 11.4.3.2.3 Japan: Genotyping Market Breakdown, by Application
        • 11.4.3.2.4 Japan: Genotyping Market Breakdown, by End-user
      • 11.4.3.3 India: Genotyping Market - Revenue and Forecast to 2031 (US$ Million)
        • 11.4.3.3.1 India: Genotyping Market Breakdown, by Product Type
        • 11.4.3.3.2 India: Genotyping Market Breakdown, by Technology
        • 11.4.3.3.3 India: Genotyping Market Breakdown, by Application
        • 11.4.3.3.4 India: Genotyping Market Breakdown, by End-user
      • 11.4.3.4 Australia: Genotyping Market - Revenue and Forecast to 2031 (US$ Million)
        • 11.4.3.4.1 Australia: Genotyping Market Breakdown, by Product Type
        • 11.4.3.4.2 Australia: Genotyping Market Breakdown, by Technology
        • 11.4.3.4.3 Australia: Genotyping Market Breakdown, by Application
        • 11.4.3.4.4 Australia: Genotyping Market Breakdown, by End-user
      • 11.4.3.5 South Korea: Genotyping Market - Revenue and Forecast to 2031 (US$ Million)
        • 11.4.3.5.1 South Korea: Genotyping Market Breakdown, by Product Type
        • 11.4.3.5.2 South Korea: Genotyping Market Breakdown, by Technology
        • 11.4.3.5.3 South Korea: Genotyping Market Breakdown, by Application
        • 11.4.3.5.4 South Korea: Genotyping Market Breakdown, by End-user
      • 11.4.3.6 Rest of APAC: Genotyping Market - Revenue and Forecast to 2031 (US$ Million)
        • 11.4.3.6.1 Rest of APAC: Genotyping Market Breakdown, by Product Type
        • 11.4.3.6.2 Rest of APAC: Genotyping Market Breakdown, by Technology
        • 11.4.3.6.3 Rest of APAC: Genotyping Market Breakdown, by Application
        • 11.4.3.6.4 Rest of APAC: Genotyping Market Breakdown, by End-user
  • 11.5 Middle East and Africa
    • 11.5.1 Middle East and Africa Genotyping Market Overview
    • 11.5.2 Middle East and Africa: Genotyping Market - Revenue and Forecast to 2031 (US$ Million)
      • 11.5.2.1 Middle East and Africa: Genotyping Market - Revenue and Forecast Analysis - by Product Type
      • 11.5.2.2 Middle East and Africa: Genotyping Market - Revenue and Forecast Analysis - by Technology
      • 11.5.2.3 Middle East and Africa: Genotyping Market - Revenue and Forecast Analysis - by Application
      • 11.5.2.4 Middle East and Africa: Genotyping Market - Revenue and Forecast Analysis - by End-user
    • 11.5.3 Middle East and Africa: Genotyping Market - Revenue and Forecast Analysis - by Country
      • 11.5.3.1 Saudi Arabia: Genotyping Market - Revenue and Forecast to 2031 (US$ Million)
        • 11.5.3.1.1 Saudi Arabia: Genotyping Market Breakdown, by Product Type
        • 11.5.3.1.2 Saudi Arabia: Genotyping Market Breakdown, by Technology
        • 11.5.3.1.3 Saudi Arabia: Genotyping Market Breakdown, by Application
        • 11.5.3.1.4 Saudi Arabia: Genotyping Market Breakdown, by End-user
      • 11.5.3.2 South Africa: Genotyping Market - Revenue and Forecast to 2031 (US$ Million)
        • 11.5.3.2.1 South Africa: Genotyping Market Breakdown, by Product Type
        • 11.5.3.2.2 South Africa: Genotyping Market Breakdown, by Technology
        • 11.5.3.2.3 South Africa: Genotyping Market Breakdown, by Application
        • 11.5.3.2.4 South Africa: Genotyping Market Breakdown, by End-user
      • 11.5.3.3 United Arab Emirates: Genotyping Market - Revenue and Forecast to 2031 (US$ Million)
        • 11.5.3.3.1 United Arab Emirates: Genotyping Market Breakdown, by Product Type
        • 11.5.3.3.2 United Arab Emirates: Genotyping Market Breakdown, by Technology
        • 11.5.3.3.3 United Arab Emirates: Genotyping Market Breakdown, by Application
        • 11.5.3.3.4 United Arab Emirates: Genotyping Market Breakdown, by End-user
      • 11.5.3.4 Rest of Middle East and Africa: Genotyping Market - Revenue and Forecast to 2031 (US$ Million)
        • 11.5.3.4.1 Rest of Middle East and Africa: Genotyping Market Breakdown, by Product Type
        • 11.5.3.4.2 Rest of Middle East and Africa: Genotyping Market Breakdown, by Technology
        • 11.5.3.4.3 Rest of Middle East and Africa: Genotyping Market Breakdown, by Application
        • 11.5.3.4.4 Rest of Middle East and Africa: Genotyping Market Breakdown, by End-user

12. Industry Landscape

  • 12.1 Overview
  • 12.2 Growth Strategies in Genotyping Market
  • 12.3 Organic Growth Strategies
    • 12.3.1 Overview
  • 12.4 Inorganic Growth Strategies
    • 12.4.1 Overview

13. Company Profiles

  • 13.1 Hoffmann-La Roche Ltd
    • 13.1.1 Key Facts
    • 13.1.2 Business Description
    • 13.1.3 Products and Services
    • 13.1.4 Financial Overview
    • 13.1.5 SWOT Analysis
    • 13.1.6 Key Developments
  • 13.2 QIAGEN NV
    • 13.2.1 Key Facts
    • 13.2.2 Business Description
    • 13.2.3 Products and Services
    • 13.2.4 Financial Overview
    • 13.2.5 SWOT Analysis
    • 13.2.6 Key Developments
  • 13.3 Merck KGaA
    • 13.3.1 Key Facts
    • 13.3.2 Business Description
    • 13.3.3 Products and Services
    • 13.3.4 Financial Overview
    • 13.3.5 SWOT Analysis
    • 13.3.6 Key Developments
  • 13.4 EUROFINS GENOMICS
    • 13.4.1 Key Facts
    • 13.4.2 Business Description
    • 13.4.3 Products and Services
    • 13.4.4 Financial Overview
    • 13.4.5 SWOT Analysis
    • 13.4.6 Key Developments
  • 13.5 Thermo Fisher Scientific Inc
    • 13.5.1 Key Facts
    • 13.5.2 Business Description
    • 13.5.3 Products and Services
    • 13.5.4 Financial Overview
    • 13.5.5 SWOT Analysis
    • 13.5.6 Key Developments
  • 13.6 BioTek Instruments, Inc.
    • 13.6.1 Key Facts
    • 13.6.2 Business Description
    • 13.6.3 Products and Services
    • 13.6.4 Financial Overview
    • 13.6.5 SWOT Analysis
    • 13.6.6 Key Developments
  • 13.7 XCELRIS GENOMICS
    • 13.7.1 Key Facts
    • 13.7.2 Business Description
    • 13.7.3 Products and Services
    • 13.7.4 Financial Overview
    • 13.7.5 SWOT Analysis
    • 13.7.6 Key Developments
  • 13.8 TRIMGEN CORPORATION
    • 13.8.1 Key Facts
    • 13.8.2 Business Description
    • 13.8.3 Products and Services
    • 13.8.4 Financial Overview
    • 13.8.5 SWOT Analysis
    • 13.8.6 Key Developments
  • 13.9 Illumina Inc
    • 13.9.1 Key Facts
    • 13.9.2 Business Description
    • 13.9.3 Products and Services
    • 13.9.4 Financial Overview
    • 13.9.5 SWOT Analysis
    • 13.9.6 Key Developments
  • 13.10 Danaher Corp
    • 13.10.1 Key Facts
    • 13.10.2 Business Description
    • 13.10.3 Products and Services
    • 13.10.4 Financial Overview
    • 13.10.5 SWOT Analysis
    • 13.10.6 Key Developments
  • 13.11 Bio-Rad Laboratories Inc
    • 13.11.1 Key Facts
    • 13.11.2 Business Description
    • 13.11.3 Products and Services
    • 13.11.4 Financial Overview
    • 13.11.5 SWOT Analysis
    • 13.11.6 Key Developments
  • 13.12 GE HealthCare Technologies Inc
    • 13.12.1 Key Facts
    • 13.12.2 Business Description
    • 13.12.3 Products and Services
    • 13.12.4 Financial Overview
    • 13.12.5 SWOT Analysis
    • 13.12.6 Key Developments
  • 13.13 Standard BioTools Inc
    • 13.13.1 Key Facts
    • 13.13.2 Business Description
    • 13.13.3 Products and Services
    • 13.13.4 Financial Overview
    • 13.13.5 SWOT Analysis
    • 13.13.6 Key Developments
  • 13.14 Laboratory Corp of America Holdings
    • 13.14.1 Key Facts
    • 13.14.2 Business Description
    • 13.14.3 Products and Services
    • 13.14.4 Financial Overview
    • 13.14.5 SWOT Analysis
    • 13.14.6 Key Developments
  • 13.15 Beckman Coulter Inc
    • 13.15.1 Key Facts
    • 13.15.2 Business Description
    • 13.15.3 Products and Services
    • 13.15.4 Financial Overview
    • 13.15.5 SWOT Analysis
    • 13.15.6 Key Developments
  • 13.16 BGI
    • 13.16.1 Key Facts
    • 13.16.2 Business Description
    • 13.16.3 Products and Services
    • 13.16.4 Financial Overview
    • 13.16.5 SWOT Analysis
    • 13.16.6 Key Developments
  • 13.17 Takara Bio Inc
    • 13.17.1 Key Facts
    • 13.17.2 Business Description
    • 13.17.3 Products and Services
    • 13.17.4 Financial Overview
    • 13.17.5 SWOT Analysis
    • 13.17.6 Key Developments
  • 13.18 DiaSorin SpA
    • 13.18.1 Key Facts
    • 13.18.2 Business Description
    • 13.18.3 Products and Services
    • 13.18.4 Financial Overview
    • 13.18.5 SWOT Analysis
    • 13.18.6 Key Developments

14. Appendix

  • 14.1 About Us
  • 14.2 Glossary of Terms

List Of Tables

  • Table 1. Genotyping Market Segmentation
  • Table 2. Genotyping Market - Revenue and Forecast to 2031 (US$ Million) - by Product Type
  • Table 3. Genotyping Market - Revenue and Forecast to 2031 (US$ Million) - by Technology
  • Table 4. Genotyping Market - Revenue and Forecast to 2031 (US$ Million) - by Application
  • Table 5. Genotyping Market - Revenue and Forecast to 2031 (US$ Million) - by End-user
  • Table 6. North America: Genotyping Market - Revenue and Forecast to 2031(US$ Million) - by Product Type
  • Table 7. North America: Genotyping Market - Revenue and Forecast to 2031(US$ Million) - by Technology
  • Table 8. North America: Genotyping Market - Revenue and Forecast to 2031(US$ Million) - by Application
  • Table 9. North America: Genotyping Market - Revenue and Forecast to 2031(US$ Million) - by End-user
  • Table 10. United States: Genotyping Market - Revenue and Forecast to 2031(US$ Million) - by Product Type
  • Table 11. United States: Genotyping Market - Revenue and Forecast to 2031(US$ Million) - by Technology
  • Table 12. United States: Genotyping Market - Revenue and Forecast to 2031(US$ Million) - by Application
  • Table 13. United States: Genotyping Market - Revenue and Forecast to 2031(US$ Million) - by End-user
  • Table 14. Canada: Genotyping Market - Revenue and Forecast to 2031(US$ Million) - by Product Type
  • Table 15. Canada: Genotyping Market - Revenue and Forecast to 2031(US$ Million) - by Technology
  • Table 16. Canada: Genotyping Market - Revenue and Forecast to 2031(US$ Million) - by Application
  • Table 17. Canada: Genotyping Market - Revenue and Forecast to 2031(US$ Million) - by End-user
  • Table 18. Mexico: Genotyping Market - Revenue and Forecast to 2031(US$ Million) - by Product Type
  • Table 19. Mexico: Genotyping Market - Revenue and Forecast to 2031(US$ Million) - by Technology
  • Table 20. Mexico: Genotyping Market - Revenue and Forecast to 2031(US$ Million) - by Application
  • Table 21. Mexico: Genotyping Market - Revenue and Forecast to 2031(US$ Million) - by End-user
  • Table 22. Europe: Genotyping Market - Revenue and Forecast to 2031(US$ Million) - by Product Type
  • Table 23. Europe: Genotyping Market - Revenue and Forecast to 2031(US$ Million) - by Technology
  • Table 24. Europe: Genotyping Market - Revenue and Forecast to 2031(US$ Million) - by Application
  • Table 25. Europe: Genotyping Market - Revenue and Forecast to 2031(US$ Million) - by End-user
  • Table 26. United Kingdom: Genotyping Market - Revenue and Forecast to 2031(US$ Million) - by Product Type
  • Table 27. United Kingdom: Genotyping Market - Revenue and Forecast to 2031(US$ Million) - by Technology
  • Table 28. United Kingdom: Genotyping Market - Revenue and Forecast to 2031(US$ Million) - by Application
  • Table 29. United Kingdom: Genotyping Market - Revenue and Forecast to 2031(US$ Million) - by End-user
  • Table 30. Germany: Genotyping Market - Revenue and Forecast to 2031(US$ Million) - by Product Type
  • Table 31. Germany: Genotyping Market - Revenue and Forecast to 2031(US$ Million) - by Technology
  • Table 32. Germany: Genotyping Market - Revenue and Forecast to 2031(US$ Million) - by Application
  • Table 33. Germany: Genotyping Market - Revenue and Forecast to 2031(US$ Million) - by End-user
  • Table 34. France: Genotyping Market - Revenue and Forecast to 2031(US$ Million) - by Product Type
  • Table 35. France: Genotyping Market - Revenue and Forecast to 2031(US$ Million) - by Technology
  • Table 36. France: Genotyping Market - Revenue and Forecast to 2031(US$ Million) - by Application
  • Table 37. France: Genotyping Market - Revenue and Forecast to 2031(US$ Million) - by End-user
  • Table 38. Spain: Genotyping Market - Revenue and Forecast to 2031(US$ Million) - by Product Type
  • Table 39. Spain: Genotyping Market - Revenue and Forecast to 2031(US$ Million) - by Technology
  • Table 40. Spain: Genotyping Market - Revenue and Forecast to 2031(US$ Million) - by Application
  • Table 41. Spain: Genotyping Market - Revenue and Forecast to 2031(US$ Million) - by End-user
  • Table 42. Italy: Genotyping Market - Revenue and Forecast to 2031(US$ Million) - by Product Type
  • Table 43. Italy: Genotyping Market - Revenue and Forecast to 2031(US$ Million) - by Technology
  • Table 44. Italy: Genotyping Market - Revenue and Forecast to 2031(US$ Million) - by Application
  • Table 45. Italy: Genotyping Market - Revenue and Forecast to 2031(US$ Million) - by End-user
  • Table 46. Rest of Europe: Genotyping Market - Revenue and Forecast to 2031(US$ Million) - by Product Type
  • Table 47. Rest of Europe: Genotyping Market - Revenue and Forecast to 2031(US$ Million) - by Technology
  • Table 48. Rest of Europe: Genotyping Market - Revenue and Forecast to 2031(US$ Million) - by Application
  • Table 49. Rest of Europe: Genotyping Market - Revenue and Forecast to 2031(US$ Million) - by End-user
  • Table 50. Asia Pacific: Genotyping Market - Revenue and Forecast to 2031(US$ Million) - by Product Type
  • Table 51. Asia Pacific: Genotyping Market - Revenue and Forecast to 2031(US$ Million) - by Technology
  • Table 52. Asia Pacific: Genotyping Market - Revenue and Forecast to 2031(US$ Million) - by Application
  • Table 53. Asia Pacific: Genotyping Market - Revenue and Forecast to 2031(US$ Million) - by End-user
  • Table 54. China: Genotyping Market - Revenue and Forecast to 2031(US$ Million) - by Product Type
  • Table 55. China: Genotyping Market - Revenue and Forecast to 2031(US$ Million) - by Technology
  • Table 56. China: Genotyping Market - Revenue and Forecast to 2031(US$ Million) - by Application
  • Table 57. China: Genotyping Market - Revenue and Forecast to 2031(US$ Million) - by End-user
  • Table 58. Japan: Genotyping Market - Revenue and Forecast to 2031(US$ Million) - by Product Type
  • Table 59. Japan: Genotyping Market - Revenue and Forecast to 2031(US$ Million) - by Technology
  • Table 60. Japan: Genotyping Market - Revenue and Forecast to 2031(US$ Million) - by Application
  • Table 61. Japan: Genotyping Market - Revenue and Forecast to 2031(US$ Million) - by End-user
  • Table 62. India: Genotyping Market - Revenue and Forecast to 2031(US$ Million) - by Product Type
  • Table 63. India: Genotyping Market - Revenue and Forecast to 2031(US$ Million) - by Technology
  • Table 64. India: Genotyping Market - Revenue and Forecast to 2031(US$ Million) - by Application
  • Table 65. India: Genotyping Market - Revenue and Forecast to 2031(US$ Million) - by End-user
  • Table 66. Australia: Genotyping Market - Revenue and Forecast to 2031(US$ Million) - by Product Type
  • Table 67. Australia: Genotyping Market - Revenue and Forecast to 2031(US$ Million) - by Technology
  • Table 68. Australia: Genotyping Market - Revenue and Forecast to 2031(US$ Million) - by Application
  • Table 69. Australia: Genotyping Market - Revenue and Forecast to 2031(US$ Million) - by End-user
  • Table 70. South Korea: Genotyping Market - Revenue and Forecast to 2031(US$ Million) - by Product Type
  • Table 71. South Korea: Genotyping Market - Revenue and Forecast to 2031(US$ Million) - by Technology
  • Table 72. South Korea: Genotyping Market - Revenue and Forecast to 2031(US$ Million) - by Application
  • Table 73. South Korea: Genotyping Market - Revenue and Forecast to 2031(US$ Million) - by End-user
  • Table 74. Rest of APAC: Genotyping Market - Revenue and Forecast to 2031(US$ Million) - by Product Type
  • Table 75. Rest of APAC: Genotyping Market - Revenue and Forecast to 2031(US$ Million) - by Technology
  • Table 76. Rest of APAC: Genotyping Market - Revenue and Forecast to 2031(US$ Million) - by Application
  • Table 77. Rest of APAC: Genotyping Market - Revenue and Forecast to 2031(US$ Million) - by End-user
  • Table 78. Middle East and Africa: Genotyping Market - Revenue and Forecast to 2031(US$ Million) - by Product Type
  • Table 79. Middle East and Africa: Genotyping Market - Revenue and Forecast to 2031(US$ Million) - by Technology
  • Table 80. Middle East and Africa: Genotyping Market - Revenue and Forecast to 2031(US$ Million) - by Application
  • Table 81. Middle East and Africa: Genotyping Market - Revenue and Forecast to 2031(US$ Million) - by End-user
  • Table 82. Saudi Arabia: Genotyping Market - Revenue and Forecast to 2031(US$ Million) - by Product Type
  • Table 83. Saudi Arabia: Genotyping Market - Revenue and Forecast to 2031(US$ Million) - by Technology
  • Table 84. Saudi Arabia: Genotyping Market - Revenue and Forecast to 2031(US$ Million) - by Application
  • Table 85. Saudi Arabia: Genotyping Market - Revenue and Forecast to 2031(US$ Million) - by End-user
  • Table 86. South Africa: Genotyping Market - Revenue and Forecast to 2031(US$ Million) - by Product Type
  • Table 87. South Africa: Genotyping Market - Revenue and Forecast to 2031(US$ Million) - by Technology
  • Table 88. South Africa: Genotyping Market - Revenue and Forecast to 2031(US$ Million) - by Application
  • Table 89. South Africa: Genotyping Market - Revenue and Forecast to 2031(US$ Million) - by End-user
  • Table 90. United Arab Emirates: Genotyping Market - Revenue and Forecast to 2031(US$ Million) - by Product Type
  • Table 91. United Arab Emirates: Genotyping Market - Revenue and Forecast to 2031(US$ Million) - by Technology
  • Table 92. United Arab Emirates: Genotyping Market - Revenue and Forecast to 2031(US$ Million) - by Application
  • Table 93. United Arab Emirates: Genotyping Market - Revenue and Forecast to 2031(US$ Million) - by End-user
  • Table 94. Rest of Middle East and Africa: Genotyping Market - Revenue and Forecast to 2031(US$ Million) - by Product Type
  • Table 95. Rest of Middle East and Africa: Genotyping Market - Revenue and Forecast to 2031(US$ Million) - by Technology
  • Table 96. Rest of Middle East and Africa: Genotyping Market - Revenue and Forecast to 2031(US$ Million) - by Application
  • Table 97. Rest of Middle East and Africa: Genotyping Market - Revenue and Forecast to 2031(US$ Million) - by End-user
  • Table 98. Recent Organic Growth Strategies in Genotyping Market
  • Table 99. Recent Inorganic Growth Strategies in the Genotyping Market
  • Table 100. Glossary of Terms, Genotyping Market

List Of Figures

  • Figure 1. Genotyping Market Segmentation, by Geography
  • Figure 2. PEST Analysis
  • Figure 3. Impact Analysis of Drivers and Restraints
  • Figure 4. Genotyping Market Revenue (US$ Million), 2021-2031
  • Figure 5. Genotyping Market Share (%) - by Product Type (2023 and 2031)
  • Figure 6. Instruments: Genotyping Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 7. Reagents and Kits: Genotyping Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 8. Bioinformatics: Genotyping Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 9. Genotyping Services: Genotyping Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 10. Genotyping Market Share (%) - by Technology (2023 and 2031)
  • Figure 11. Microarray: Genotyping Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 12. Capillary Electrophoresis: Genotyping Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 13. Sequencing: Genotyping Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 14. Polymerase Chain Reaction (PCR): Genotyping Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 15. Matrix-Assisted Laser Desorption / MALDI-TOF: Genotyping Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 16. Other Technologies: Genotyping Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 17. Genotyping Market Share (%) - by Application (2023 and 2031)
  • Figure 18. Pharmacogenomics: Genotyping Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 19. Diagnostics and Personalized Medicine: Genotyping Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 20. Animal Genetics: Genotyping Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 21. Agricultural Biotechnology: Genotyping Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 22. Other Applications: Genotyping Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 23. Genotyping Market Share (%) - by End-user (2023 and 2031)
  • Figure 24. Pharmaceutical and Biopharmaceutical Companies: Genotyping Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 25. Diagnostic and Research Laboratories: Genotyping Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 26. Academic Institutes: Genotyping Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 27. Other End Users: Genotyping Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 28. Genotyping Market Breakdown by Region, 2023 and 2031 (%)
  • Figure 29. North America: Genotyping Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 30. North America: Genotyping Market Breakdown, by Key Countries, 2023 and 2031 (%)
  • Figure 31. United States: Genotyping Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 32. Canada: Genotyping Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 33. Mexico: Genotyping Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 34. Europe: Genotyping Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 35. Europe: Genotyping Market Breakdown, by Key Countries, 2023 and 2031 (%)
  • Figure 36. United Kingdom: Genotyping Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 37. Germany: Genotyping Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 38. France: Genotyping Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 39. Spain: Genotyping Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 40. Italy: Genotyping Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 41. Rest of Europe: Genotyping Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 42. Asia Pacific: Genotyping Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 43. Asia Pacific: Genotyping Market Breakdown, by Key Countries, 2023 and 2031 (%)
  • Figure 44. China: Genotyping Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 45. Japan: Genotyping Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 46. India: Genotyping Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 47. Australia: Genotyping Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 48. South Korea: Genotyping Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 49. Rest of APAC: Genotyping Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 50. Middle East and Africa: Genotyping Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 51. Middle East and Africa: Genotyping Market Breakdown, by Key Countries, 2023 and 2031 (%)
  • Figure 52. Saudi Arabia: Genotyping Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 53. South Africa: Genotyping Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 54. United Arab Emirates: Genotyping Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 55. Rest of Middle East and Africa: Genotyping Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 56. Growth Strategies in Genotyping Market